Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation

Background: Evidence on the safety and effectiveness of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Atrial Fibrillation (AF) patients with cancer is rather limited, so we performed this meta-analysis to compare the efficacy and safety of NOACs with vitamin K antagonists (VKAs) in real-world patients with AF and cancer.

Download Full-text

Comparative Efficacy and Safety of the Non–Vitamin K Antagonist Oral Anticoagulants for Patients with Nonvalvular Atrial Fibrillation

Seminars in Thrombosis and Hemostasis ◽

10.1055/s-0035-1544156 ◽

2015 ◽

Vol 41 (02) ◽

pp. 146-153 ◽

Cited By ~ 8

Author(s):

Keitaro Senoo ◽

Gregory Lip

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Nonvalvular Atrial Fibrillation

Download Full-text

Efficacy and safety of non-vitamin K-antagonist oral anticoagulants for retinal vascular diseases in patients with atrial fibrillation: Korean cohort study

Scientific Reports ◽

10.1038/s41598-020-61609-8 ◽

2020 ◽

Vol 10 (1) ◽

Author(s):

Se-Jun Park ◽

Eunyoung Lee ◽

Kihwang Lee ◽

Bumhee Park ◽

Yoo-Ri Chung

Keyword(s):

Atrial Fibrillation ◽

Cohort Study ◽

Vitamin K ◽

Oral Anticoagulants ◽

Vascular Diseases ◽

Vitamin K Antagonist ◽

Efficacy And Safety

Download Full-text

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation

Renal Function and Treatment Persistence with Non-Vitamin K Antagonist Oral Anticoagulants in Japanese Patients with Atrial Fibrillation: A Single-Center Experience

CORRIGENDUM: Use of Oral Anticoagulants According to the Degree of Renal Impairment in Japanese Patients With Atrial Fibrillation – Which Non-Vitamin K Antagonist Oral Anticoagulant to Select? –

Special considerations for therapeutic choice of non-vitamin K antagonist oral anticoagulants for Japanese patients with nonvalvular atrial fibrillation

Efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and chronic kidney disease stage G4

Efficacy and Safety of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study

Letter by Tong et al Regarding Article, “Efficacy and Safety of the Use of Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials”

Changes in renal function in patients with atrial fibrillation: Efficacy and safety of the non–vitamin K antagonist oral anticoagulants

Ef﻿ficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer in Real World: Meta-Analysis of Retrospective Observational Studies

Comparative Efficacy and Safety of the Non–Vitamin K Antagonist Oral Anticoagulants for Patients with Nonvalvular Atrial Fibrillation

Efficacy and safety of non-vitamin K-antagonist oral anticoagulants for retinal vascular diseases in patients with atrial fibrillation: Korean cohort study

CORRIGENDUM: Use of Oral Anticoagulants According to the Degree of Renal Impairment in Japanese Patients With Atrial Fibrillation　– Which Non-Vitamin K Antagonist Oral Anticoagulant to Select? –

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer in Real World: Meta-Analysis of Retrospective Observational Studies